Target intelligence / Profile preview

Protocadherin 19 pseudogene

Molecular classification
Other (pseudogene)
01

Overview

Protocadherin 19 pseudogene (ENSG00000276945) is a non-coding DNA sequence similar to the gene encoding protocadherin 19 (PCDH19) but is classified as a pseudogene, meaning it does not produce a functional protein. Pseudogenes are considered nonfunctional genomic relics and do not have known biological activity, do not participate in diseases as direct causative agents, and are not considered therapeutic targets. Explanation and Context - Pseudogene status: The provided Ensembl ID (ENSG00000276945) refers to a pseudogene; therefore, it does not encode a functional protein product and cannot act as a receptor, enzyme, transporter, or other druggable target[3]. - Not a therapeutic target: Unlike the functional gene PCDH19 (ENSG00000165194), which is implicated in epilepsy syndromes and serves as a recognized target in neurodevelopmental disease biology[1][2][3][4], pseudogenes typically do not possess such clinical or therapeutic relevance. - No drugs or mechanisms: No drugs are designed to interact with pseudogenes, nor are there mechanisms of action, biomarker use, or safety concerns associated with them in therapy. If you intended to inquire about functional PCDH19, see ENSG00000165194 and its protein product, which is involved in cell adhesion in the nervous system and associated with epilepsy and neurodevelopmental disorders[1][2][3][4]. The pseudogene should not be mistaken for the gene encoding the active, clinically relevant protein.

Other names
PCDH19PPCDH19 pseudogene

Beyond the preview

Go deeper on Protocadherin 19 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protocadherin 19 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call